Trial Profile
An Open-Label, Single-dose, Randomized, Five-Period Cross-over to Compare Pharmacokinetics Profiles of Z7200 and Symbicort Turbohaler, With and Without Charcoal Blockade in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jan 2022
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Zambon SpA
- 04 Mar 2015 Status changed from recruiting to completed, according to the ClinicalTrials.gov record.
- 16 Dec 2014 Planned End Date changed from 1 Nov 2014 to 1 Jan 2015, according to the ClinicalTrials.gov record.
- 16 Dec 2014 Planned primary completion date changed from 1 Nov 2014 to 1 Jan 2015, according to the ClinicalTrials.gov record.